Currently out of the existing stock ratings of Jeffrey Holford, 72 are a BUY (79.12%), 17 are a HOLD (18.68%), 2 are a SELL (2.2%).

Jeffrey Holford

Work Performance Price Targets & Ratings Chart

Analyst Jeffrey Holford, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 43.85% achieved within 936 days. Previously, Jeffrey Holford worked at JEFFERIES.

Jeffrey Holford’s has documented 139 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 01-Feb-2018.

Wall Street Analyst Jeffrey Holford

Analyst best performing recommendations are on MRK (MERCK MPANY).
The best stock recommendation documented was for MRK (MERCK MPANY) at 12/19/2016. The price target of $45.8 was fulfilled within 2 days with a profit of $0.76 (1.63%) receiving and performance score of 8.16.

Average potential price target upside

of $42.45 (93.35%) on ABBV (ABBVIE).
of $36.31 (31.88%) on JNJ (JOHNSON & JOHNSON).
of $31.31 (47.17%) on LLY (ELI LILLY AND COMPANY).

ABBV AbbVie ABT Abbott Laboratories AZN AstraZeneca PLC ADR BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer JNJ Johnson & Johnson ZTS Zoetis

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Geoff Meacham (BAML)